logo
Share SHARE
FONT-SIZE Plus   Neg

L-3 Communications Q1 Results Beat Estimates; Lifts Full-year Guidance

Defense contractor L-3 Communications Holdings Inc. (LLL) reported Thursday a small drop in first-quarter profit as sales edged down. However, the results were better than analysts' estimates. The company also lifted its full-year guidance.

Net income attributable to L-3 dropped a percent to $201 million from $204 million last year, but earnings per share grew 9 percent to $2.01 from last year's $1.85 on lower shares outstanding.

Net sales edged down 0.4 percent to $3.59 billion from $3.60 billion last year.

On average, analysts polled by Thomson Reuters expected the company to earn $1.88 per share on revenues of $3.46 billion.

Michael Strianese, chairman, president and chief executive officer, said, "Orders grew 22% compared to last year, driven by several international new business wins and earlier than expected orders for several of our DoD and international contracts, resulting in a book-to-bill ratio of 1.14x. We ended the quarter with funded backlog of $11.4 billion."

Looking ahead, the company lifted its earnings guidance to a new range of $8.45 to $ 8.60 per share from the previous estimate of $8.35 to $ 8.55 per share. It anticipates net sales to be between $14.55 billion and $14.75 billion, up from the prior forecast of $14.40 billion to $14.60 billion.

Analysts expect earnings of $8.49 per share on revenues of $14.49 billion for the year.

The company cited the acquisition of the Kollmorgen Electro-Optical business and the re-alignment of the TRL business as reasons for the guidance update.

LLL also noted that the guidance continues to include the estimated results of the Engility businesses and excludes $15 million of estimated spin-off transaction expenses. L-3 expects to complete the spin-off around the middle of 2012.

"During the quarter, we repurchased $138 million of our common stock and paid dividends of $49 million, and our board of directors increased L-3's quarterly cash dividend by 11% to $0.50 per share. This dividend increase marks our eighth consecutive annual increase," Strianese added.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year. As the din settles down on a dismal quarter at one of the world's exciting tech company, it is time to sit back and take stock of what went wrong and will the wrong be righted in the near term?
comments powered by Disqus
Follow RTT